Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2026 Filed Mar 30, 2026 21:58 UTC |
Arno AndrewDirector
|
GrantOptions (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001437749-26-010378 · rdgdoc.xml · derivative · entry 1 Arno Andrew · CIK 0001472122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-03-26 F1 · derivative.exercise_date: Options vest 100% on 180 day anniversary of grant date. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 17:58 UTC |
ANDERSON PHILIP JChief Financial Officer
|
GrantOptions (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001437749-26-010381 · rdgdoc.xml · derivative · entry 1 ANDERSON PHILIP J · CIK 0001352119 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-03-26 F1 · derivative.exercise_date: Options vest 100% on 180 day anniversary of grant date. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 17:58 UTC |
JENKINS DAVID ADirector · Chairman of the Board and CEO
|
GrantOptions (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001437749-26-010382 · rdgdoc.xml · derivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-03-26 F1 · derivative.exercise_date: Options vest 100% on 180 day anniversary of grant date. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 17:57 UTC |
COLOMBATTO MARTIN JDirector
|
GrantOptions (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001437749-26-010375 · rdgdoc.xml · derivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-03-26 F1 · derivative.exercise_date: Options vest 100% on 180 day anniversary of grant date. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 17:58 UTC |
Caruso James JosephDirector
|
GrantOptions (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001437749-26-010376 · rdgdoc.xml · derivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-03-26 F1 · derivative.exercise_date: Options vest 100% on 180 day anniversary of grant date. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 16:16 UTC |
JENKINS DAVID ADirector · Chairman of the Board and CEO
|
OtherSeries J Preferred Stock · Derivative | 6,998.195 | Not disclosed Strike: $1.56 | Not disclosed |
DisclosureSEC source: 0001437749-26-004551 · rdgdoc.xml · derivative · entry 2 JENKINS DAVID A · CIK 0001279803 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,998.195 Underlying: Common Stock · 4,486,022 shares Expires not disclosed F1 · kind: Series J Exchange Agreement entered into with the Company to cancel accrued royalty amount and terminate royalty right in exchange for Series J Preferred Stock, as more fully described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 12, 2026 (the "Form 8-K"). F4 · price: The consideration and price paid for the Series J Preferred Stock is more fully described in the Form 8-K. F2 · derivative.exercise_date: Series J Preferred Stock is not exercisable until stockholder approval is received, as more fully described in the Form 8-K. F3 · derivative.expiration_date: Series J Preferred Stock has no expiration date. F5 · ownership.nature: Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 16:16 UTC |
JENKINS DAVID ADirector · Chairman of the Board and CEO
|
OtherSeries J Preferred Stock · Derivative | 2,491.293 | Not disclosed Strike: $1.56 | Not disclosed |
DisclosureSEC source: 0001437749-26-004551 · rdgdoc.xml · derivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,491.293 Underlying: Common Stock · 1,596,983 shares Expires not disclosed F1 · kind: Series J Exchange Agreement entered into with the Company to cancel accrued royalty amount and terminate royalty right in exchange for Series J Preferred Stock, as more fully described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 12, 2026 (the "Form 8-K"). F4 · price: The consideration and price paid for the Series J Preferred Stock is more fully described in the Form 8-K. F2 · derivative.exercise_date: Series J Preferred Stock is not exercisable until stockholder approval is received, as more fully described in the Form 8-K. F3 · derivative.expiration_date: Series J Preferred Stock has no expiration date. Read SEC document |
| December 31, 2025 Filed Jan 20, 2026 16:20 UTC |
JENKINS DAVID AChairman of the Board and CEO
|
OtherSeries M Common Stock Purchase Warrant · Derivative | 170,000 | $1.56 Strike: $1.56 | $265,200.00 |
DisclosureSEC source: 0001437749-26-001574 · rdgdoc.xml · derivative · entry 2 JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote 3 Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires not disclosed F1 · derivative.exercise_date: Initial Exercise Date is any time on or after the Stockholder Approval Date. F2 · derivative.expiration_date: Termination Date equals the Five and One Half (5.5) Year Anniversary of the Initial Exercise Date F3 · ownership.nature: Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP Read SEC document |
| December 31, 2025 Filed Jan 20, 2026 16:20 UTC |
JENKINS DAVID AChairman of the Board and CEO
|
OtherSeries M Common Stock Purchase Warrant · Derivative | 170,000 | $1.56 Strike: $1.56 | $265,200.00 |
DisclosureSEC source: 0001437749-26-001574 · rdgdoc.xml · derivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires not disclosed F1 · derivative.exercise_date: Initial Exercise Date is any time on or after the Stockholder Approval Date. F2 · derivative.expiration_date: Termination Date equals the Five and One Half (5.5) Year Anniversary of the Initial Exercise Date Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:45 UTC |
JENKINS DAVID AChairman of the Board and CEO
|
ConversionSeries X Convertible Preferred Stock · Derivative | 18.691 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037162 · rdgdoc.xml · derivative · entry 6 JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date F2 · ownership.nature: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:45 UTC |
JENKINS DAVID AChairman of the Board and CEO
|
ConversionSeries X Convertible Preferred Stock · Derivative | 5,860.54 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037162 · rdgdoc.xml · derivative · entry 5 JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date F1 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:45 UTC |
JENKINS DAVID AChairman of the Board and CEO
|
ConversionSeries X Convertible Preferred Stock · Derivative | 2,292.339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037162 · rdgdoc.xml · derivative · entry 4 JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:45 UTC |
JENKINS DAVID AChairman of the Board and CEO
|
ConversionCommon Stock | 98 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037162 · rdgdoc.xml · nonDerivative · entry 3 JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:45 UTC |
JENKINS DAVID AChairman of the Board and CEO
|
ConversionCommon Stock | 30,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037162 · rdgdoc.xml · nonDerivative · entry 2 JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 34,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:45 UTC |
JENKINS DAVID AChairman of the Board and CEO
|
ConversionCommon Stock | 12,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037162 · rdgdoc.xml · nonDerivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:54 UTC |
Caruso James JosephDirector
|
ConversionSeries X Convertible Preferred Stock · Derivative | 7.932 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037173 · rdgdoc.xml · derivative · entry 2 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:54 UTC |
Caruso James JosephDirector
|
ConversionCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037173 · rdgdoc.xml · nonDerivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 20:34 UTC |
Arno AndrewDirector
|
GrantOptions (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001654954-25-009661 · section16.xml · derivative · entry 1 Arno Andrew · CIK 0001472122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-08-12 F1 · derivative.exercise_date: Options vests 1/3 per year beginning on the first anniversary of the grant date. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:31 UTC |
JENKINS DAVID ADirector · Exec. Chairman of the Board
|
GrantOptions (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001654954-25-009658 · section16.xml · derivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Director · Exec. Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2035-08-12 F1 · derivative.exercise_date: Options vests 20% per year beginning on first anniversary of grant date. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:33 UTC |
COLOMBATTO MARTIN JDirector
|
GrantOptions (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001654954-25-009659 · section16.xml · derivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-08-12 F1 · derivative.exercise_date: Options vests 1/3 per year beginning on first anniversary of grant date. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:33 UTC |
Caruso James JosephDirector
|
GrantOptions (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001654954-25-009660 · section16.xml · derivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-08-12 F1 · derivative.exercise_date: Options vests 1/3 per year beginning on first anniversary of grant date. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 16:38 UTC |
Jacques Marie-ClaudeChief Commercial Officer
|
GrantStock Option · Derivative | 125,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001437749-25-002430 · rdgdoc.xml · derivative · entry 1 Jacques Marie-Claude · CIK 0002022186 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common stock · 125,000 shares Expires 2035-01-29 F1 · derivative.exercise_date: 20% exercisable on January 29, 2025, 20% exercisable on January 29, 2026, 20% exercisable on January 29, 2027, 20% exercisable on January 29, 2028, and 20% exercisable on January 29, 2029. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:37 UTC |
Arno AndrewDirector
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001437749-25-002426 · rdgdoc.xml · derivative · entry 1 Arno Andrew · CIK 0001472122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock · 100,000 shares Expires 2035-01-29 F1 · derivative.exercise_date: 33.33% exercisable on January 29, 2025, 33.33% exercisable on January 29, 2026, and 33.34% exercisable on January 29, 2027. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 16:39 UTC |
JENKINS DAVID AChairman of the Board and CEO
|
GrantStock Option · Derivative | 450,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001437749-25-002432 · rdgdoc.xml · derivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Common stock · 450,000 shares Expires 2035-01-29 F1 · derivative.exercise_date: 90,000 shares exercisable January 29, 2025, 120,000 shares exercisable January 29, 2026, 120,000 shares exercisable January 29, 2027, and 120,000 shares exercisable January 29, 2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 16:39 UTC |
COLOMBATTO MARTIN JDirector
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001437749-25-002433 · rdgdoc.xml · derivative · entry 3 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-01-29 F2 · derivative.exercise_date: 33.33% exercisable on January 29, 2025, 33.33% exercisable on January 29, 2026, and 33.34% exercisable on January 29, 2027. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 16:39 UTC |
COLOMBATTO MARTIN JDirector
|
SaleCommon Stock | 3 | $0.40 | $1.20 |
DisclosureSEC source: 0001437749-25-002433 · rdgdoc.xml · nonDerivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 0 F1 · ownership.nature: Shares held of record by the M Colombatto Trust, for which the reporting person serves as trustee. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 16:37 UTC |
Caruso James JosephDirector
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001437749-25-002428 · rdgdoc.xml · derivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock · 100,000 shares Expires 2035-01-29 F1 · derivative.exercise_date: 33.33% exercisable on January 29, 2025, 33.33% exercisable on January 29, 2026, and 33.34% exercisable on January 29, 2027. Read SEC document |
| January 06, 2025 Filed Mar 3, 2025 17:17 UTC |
ANDERSON PHILIP JChief Financial Officer
|
GrantOption (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001654954-25-002227 · section16.xml · derivative · entry 1 ANDERSON PHILIP J · CIK 0001352119 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2035-01-06 F1 · derivative.exercise_date: Options vest 1/36 every month beginning February 6, 2025 Read SEC document |
| May 01, 2024 Filed May 3, 2024 17:02 UTC |
Jacques Marie-ClaudeChief Commercial Officer
|
GrantOption (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001654954-24-005560 · section16.xml · derivative · entry 1 Jacques Marie-Claude · CIK 0002022186 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2034-05-01 F1 · derivative.exercise_date: Options vests annually for five years. Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 16:15 UTC |
JENKINS DAVID ADirector · Executive Chairman and CEO
|
PurchaseCommon Stock | 9,528 | $0.60 | $5,693.93 |
DisclosureSEC source: 0001654954-24-000874 · section16.xml · nonDerivative · entry 2 JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,856 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4164 to $0.4319, inclusive on January 22, 2024 and $0.5673 to $0.6304, inclusive on January 23, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 16:15 UTC |
JENKINS DAVID ADirector · Executive Chairman and CEO
|
PurchaseCommon Stock | 9,528 | $0.43 | $4,092.28 |
DisclosureSEC source: 0001654954-24-000874 · section16.xml · nonDerivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,328 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4164 to $0.4319, inclusive on January 22, 2024 and $0.5673 to $0.6304, inclusive on January 23, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above. Read SEC document |
| January 19, 2024 Filed Jan 22, 2024 16:15 UTC |
JENKINS DAVID ADirector · Executive Chairman and CEO
|
PurchaseCommon Stock | 8,470 | $0.42 | $3,594.67 |
DisclosureSEC source: 0001654954-24-000790 · section16.xml · nonDerivative · entry 2 JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $00.3989 to $00.4174, inclusive on January 18, 2024 and $00.4211 to $00.4475, inclusive on January 19, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above. Read SEC document |
| January 18, 2024 Filed Jan 22, 2024 16:15 UTC |
JENKINS DAVID ADirector · Executive Chairman and CEO
|
PurchaseCommon Stock | 8,470 | $0.41 | $3,491.33 |
DisclosureSEC source: 0001654954-24-000790 · section16.xml · nonDerivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302,330 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $00.3989 to $00.4174, inclusive on January 18, 2024 and $00.4211 to $00.4475, inclusive on January 19, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 16:15 UTC |
JENKINS DAVID ADirector · Executive Chairman and CEO
|
PurchaseCommon Stock | 8,470 | $0.39 | $3,313.46 |
DisclosureSEC source: 0001654954-24-000736 · section16.xml · nonDerivative · entry 2 JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,860 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $00.3820 to $00.3923, inclusive on January 16, 2024 and $00.3898 to $00.3968, inclusive on January 17, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 16:15 UTC |
JENKINS DAVID ADirector · Executive Chairman and CEO
|
PurchaseCommon Stock | 7,793 | $0.39 | $3,009.66 |
DisclosureSEC source: 0001654954-24-000736 · section16.xml · nonDerivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,390 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $00.3820 to $00.3923, inclusive on January 16, 2024 and $00.3898 to $00.3968, inclusive on January 17, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:31 UTC |
Thomassen MargritInterim CFO and Secretary
|
GrantOptions (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001654954-24-000422 · section16.xml · derivative · entry 1 Thomassen Margrit · CIK 0002006843 · Interim CFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-08 F1 · derivative.exercise_date: Options vests 20% per year beginning on first anniversary of grant date. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:31 UTC |
Francis, John P.Director
|
GrantOptions (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001654954-24-000423 · section16.xml · derivative · entry 1 Francis, John P. · CIK 0001480019 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-08 F1 · derivative.exercise_date: Options vests 8 1/3% every three months beginning on April 8, 2024. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:31 UTC |
COLOMBATTO MARTIN JDirector
|
GrantOptions (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001654954-24-000421 · section16.xml · derivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 25,000 shares Expires 2034-01-08 F1 · derivative.exercise_date: Options vests 8 1/3% every three months beginning on April 8, 2024. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:30 UTC |
Caruso James JosephDirector
|
GrantOptions (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001654954-24-000420 · section16.xml · derivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-08 F1 · derivative.exercise_date: Options vests 8 1/3% every three months beginning April 8, 2024. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:18 UTC |
JENKINS DAVID ADirector · Ex. Chairman of the Board
|
ConversionSeries X Convertible Preferred Stock · Derivative | 2.264 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003613 · section16.xml · derivative · entry 6 JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 18.691 Underlying: Common Stock · 18,691 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American. F5 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. F3 · ownership.nature: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:18 UTC |
JENKINS DAVID ADirector · Ex. Chairman of the Board
|
ConversionSeries X Convertible Preferred Stock · Derivative | 709.703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003613 · section16.xml · derivative · entry 5 JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,860.54 Underlying: Common Stock · 5,860,540 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American. F5 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. F2 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:18 UTC |
JENKINS DAVID ADirector · Ex. Chairman of the Board
|
ConversionSeries X Convertible Preferred Stock · Derivative | 277.597 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003613 · section16.xml · derivative · entry 4 JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,292.339 Underlying: Common Stock · 2,292,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American. F5 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:18 UTC |
JENKINS DAVID ADirector · Ex. Chairman of the Board
|
ConversionCommon Stock | 2,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003613 · section16.xml · nonDerivative · entry 3 JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. F3 · ownership.nature: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:18 UTC |
JENKINS DAVID ADirector · Ex. Chairman of the Board
|
ConversionCommon Stock | 709,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003613 · section16.xml · nonDerivative · entry 2 JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 709,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. F2 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:18 UTC |
JENKINS DAVID ADirector · Ex. Chairman of the Board
|
ConversionCommon Stock | 277,597 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003613 · section16.xml · nonDerivative · entry 1 JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:20 UTC |
Caruso James JosephDirector
|
ConversionSeries X Convertible Preferred Stock · Derivative | 1.779 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003615 · section16.xml · derivative · entry 2 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.932 Underlying: Common Stock · 7,932 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American. F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 17:20 UTC |
Caruso James JosephDirector
|
ConversionCommon Stock | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003615 · section16.xml · nonDerivative · entry 1 Caruso James Joseph · CIK 0001397215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 21:22 UTC |
Meline SusanneDirector
|
ConversionSeries X Convertible Preferred Stock · Derivative | 2.575 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003617 · section16.xml · derivative · entry 5 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 11.481 Underlying: Common Stock · 11,481 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. F5 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 21:22 UTC |
Meline SusanneDirector
|
ConversionCommon Stock | 2,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003617 · section16.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 2,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 17:20 UTC |
JENKINS DAVID ADirector · Executive Chairman of Board
|
GrantSeries X Convertible Preferred Stock · Derivative | 6,570.243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-003033 · doc4.xml · derivative · entry 3 JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman of Board 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,570.243 Underlying: Common Stock · 6,570,243 shares Expires not disclosed F1 · derivative.exercise_price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. F2 · kind: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000). F1 · price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. F1 · derivative.exercise_date: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date F5 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.